Product Information
BUSPIRONE HCL 10 MG TABLET is a generic product labeled by Nivagen Pharmaceuticals Inc., priced at $0.0308 per EA under NDC 75834026801. Its NADAC has been published 207 times since Mar 24, 2021.
FDA first approved this application on May 3, 2018. Its Orange Book therapeutic-equivalence code is BX.
Strength
10 mg/1
Manufacturer
Nivagen Pharmaceuticals Inc.NDC
75834026801
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
2/19/2025
Active Ingredients
BUSPIRONE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA209696FDA Approved
5/3/2018
TE Code
BX
On Market Since
2/15/2021
Price Statistics
The NADAC for BUSPIRONE HCL 10 MG TABLET has been published 207 times since Mar 24, 2021, and over the history we have for it it has declined 24.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0308 per EA |
|---|---|
| All-time high | $0.0419 (Mar 16, 2022) |
| All-time low | $0.0258 (Nov 20, 2024) |
| Median price | $0.0375 |
| Average price | $0.0363 |
| Largest weekly change | +24.0% (Aug 21, 2024) |
| Weeks tracked | 207 |
| Tracking since | Mar 24, 2021 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
-17.8%
5Y
-21.5%
All
-24.9%
Last surveyed Mar 5, 2025 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 9 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 9% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of BUSPIRONE HCL 10 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for BUSPIRONE HCL 10 MG TABLET, manufactured by Nivagen Pharmaceuticals Inc., is $0.0308 per EA (NDC 75834026801), effective Mar 5, 2025.
How has the price of BUSPIRONE HCL 10 MG TABLET changed over time?
Over the history we have for it, the NADAC for BUSPIRONE HCL 10 MG TABLET has declined 24.9%. It has been tracked across 207 weekly CMS publications since Mar 24, 2021.
What are the highest and lowest recorded NADAC prices for BUSPIRONE HCL 10 MG TABLET?
Since Mar 24, 2021, the NADAC for BUSPIRONE HCL 10 MG TABLET has ranged from a low of $0.0258 (Nov 20, 2024) to a high of $0.0419 (Mar 16, 2022), with a median of $0.0375 per EA.
Are there cheaper alternatives to BUSPIRONE HCL 10 MG TABLET?
Yes. 9 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, BUSPIRONE HCL 10 MG TABLET, is $0.0279 per EA — about 9% below BUSPIRONE HCL 10 MG TABLET.
Who manufactures BUSPIRONE HCL 10 MG TABLET?
BUSPIRONE HCL 10 MG TABLET (NDC 75834026801) is labeled by Nivagen Pharmaceuticals Inc., and CMS classifies it as a generic product.